American Analyst Ratings
Analysts today are generally optimistic, favoring healthcare, technology, and energy stocks, with many Buy/Outperform reiterations and target adjustments reflecting confidence in growth and resilience, while selectively moderating outlooks for cyclical or consumer-facing companies amid market and macroeconomic uncertainties.
295 Analyst Updates
AbbVie (NYSE: ABBV) was reiterated Outperform by BMO Capital Markets.
AbbVie (NYSE: ABBV) was reiterated Outperform by William Blair.
Abeona Therapeutics (NASDAQ: ABEO) was reiterated Outperform by Oppenheimer.
A10 Networks (NYSE: ATEN) received a $25 price target from Loop Capital.
A10 Networks (NYSE: ATEN) received a $9 price target from DNB Markets.
Adeia (NASDAQ: ADEA) was reiterated Buy by BWS Financial with a $30 target price.
Adeia (NASDAQ: ADEA) received a $40 target price from Rosenblatt Securities.
Adobe (NASDAQ: ADBE) was reiterated Outperform by Royal Bank of Canada with a $430 target price.
Adobe (NASDAQ: ADBE) had its target price lowered to $405 from $420 by Wells Fargo, maintaining an Overweight rating.
Agree Realty (NYSE: ADC) had its target price raised to $91 from $82 by UBS Group, maintaining a Buy rating.
Agilent Technologies (NYSE: A) had its target price lowered to $54 from $60 by Royal Bank of Canada while maintaining an Outperform rating.
AGI (NASDAQ: AGBK) was initiated with an Overweight rating and $21 target by Morgan Stanley.
AGI (NASDAQ: AGBK) was initiated with an Outperform rating and $15 target by Oppenheimer.
AGI (NASDAQ: AGBK) was initiated with a Positive rating and $17 target by Susquehanna.
AGI (NASDAQ: AGBK) was initiated with a Buy rating and $18 target by Citigroup.
AGI (NASDAQ: AGBK) was initiated with a Buy rating and $19 target by Goldman Sachs.
AGI (NASDAQ: AGBK) was initiated with an Outperform rating and $15 target by Itau BBA Securities.
Aktis Oncology (NASDAQ: AKTS) was initiated with a Buy rating and $30 target by HC Wainwright.
Alamo Group (NYSE: ALG) was reiterated Neutral by DA Davidson with a $190 target price.
Alaska Air Group (NYSE: ALK) had its target lowered to $54 from $63 by TD Cowen, maintaining a Buy rating.
Algonquin Power & Utilities (NYSE: AQN) had its target lowered to $6.00 from $6.50 by TD Cowen, maintaining a Hold rating.
Algonquin Power & Utilities (NYSE: AQN) was upgraded to Outperform from Market Perform by Raymond James, with the target raised to $7.25 from $6.50.
Algonquin Power & Utilities (NYSE: AQN) had its target lowered to $7.00 from $7.25 by Desjardins, maintaining a Buy rating.
Algonquin Power & Utilities (NYSE: AQN) had its target lowered to $7.25 from $7.50 by National Bank Financial, maintaining an Outperform rating.
Allient (NASDAQ: ALNT) was reiterated Buy by Craig Hallum with a $75 target price.
Alta Equipment Group (NYSE: ALTG) was upgraded to Outperform from Market Perform by Raymond James, with a $9.50 target price.
Altria Group (NYSE: MO) had its target raised to $74 from $67 by UBS Group, maintaining a Buy rating.
American Airlines Group (NASDAQ: AAL) had its target lowered to $13 from $17 by TD Cowen, maintaining a Buy rating.
American Electric Power (NASDAQ: AEP) had its target raised to $135 from $132 by UBS Group.
American Homes 4 Rent (NYSE: AMH) had its target lowered to $39 from $40 by Morgan Stanley, maintaining an Overweight rating.
American Integrity Insurance Group (NYSE: AII) had its target lowered to $28 from $29 by Keefe, Bruyette & Woods, maintaining an Outperform rating.
Amprius Technologies (NYSE: AMPX) had its target raised to $22 from $16 by B. Riley Financial, maintaining a Buy rating.
APA Corp (NASDAQ: APA) had its target raised to $26 from $22 by Jefferies Financial Group.
APA Corp (NASDAQ: APA) had its target raised to $45 from $39 by Wolfe Research.
ArcBest (NASDAQ: ARCB) had its target raised to $107 from $105 by Citigroup, maintaining a Buy rating.
Ardent Health (NYSE: ARDT) received an Outperform rating and $13 target price from Royal Bank of Canada.
argenx (NASDAQ: ARGX) was reiterated Outperform by Wedbush with a $1,000 target price.
Array Digital Infrastructure (NYSE: AD) had its target lowered to $54 from $60 by Royal Bank of Canada, maintaining an Outperform rating.
AT&T (NYSE: T) had its target raised to $31 from $29.50 by Scotiabank, maintaining a Sector Perform rating.
AudioEye (NASDAQ: AEYE) had its target lowered to $12 from $18 by HC Wainwright, maintaining a Buy rating.
AutoZone (NYSE: AZO) was upgraded to Buy from Hold by Argus with a $4,325 target price.
Avista (NYSE: AVA) was initiated with an Equal Weight rating and $40 target price by Barclays.
BHP Group (NYSE: BHP) had its price target lowered to $48 from $49.50 by Bernstein, maintaining a Market Perform rating.
Biohaven (NYSE: BHVN) was reiterated Strong Buy by Raymond James.
Bridger Aerospace Group (NASDAQ: BAER) had its price target lowered to $5.00 from $5.25 by Canaccord Genuity, maintaining a Buy rating.
Broadstone Net Lease (NYSE: BNL) had its price target raised to $20 from $19 by UBS Group, maintaining a Neutral rating.
BancFirst (NASDAQ: BANF) was reiterated Neutral by DA Davidson with a $125 price target.
Benitec Biopharma (NASDAQ: BNTC) was reiterated Buy by TD Cowen.
Benitec Biopharma (NASDAQ: BNTC) was reiterated Buy by HC Wainwright with a $32 price target.
Cameco (NYSE: CCJ) received a $202 price target from Canadian Imperial Bank of Commerce.
Cardinal Health (NYSE: CAH) was reiterated Outperform by Leerink Partners with a $275 price target.
Caterpillar (NYSE: CAT) had its price target raised to $785 from $760 by Citigroup, maintaining a Buy rating.
Celanese (NYSE: CE) was upgraded to Buy from Hold by Vertical Research with a $60 price target.
Celanese (NYSE: CE) was upgraded to Buy from Hold by Tudor Pickering.
Chipotle Mexican Grill (NYSE: CMG) was reiterated Buy by Stifel.
Citizens Financial Group (NYSE: CFG) was upgraded to Outperform from Neutral by Robert W. Baird with a $65 price target.
Cognex (NASDAQ: CGNX) was upgraded to Neutral from Underweight by JPMorgan with a $55 price target.
Coinbase Global (NASDAQ: COIN) had its price target lowered to $277 from $288 by Redburn.
Corteva (NYSE: CTVA) had its price target raised to $74 from $72 by BNP Paribas Exane.
Coterra Energy (NYSE: CTRA) had its price target raised to $28 from $26 by Jefferies.
Coterra Energy (NYSE: CTRA) had its price target raised to $41 from $34 by Raymond James.
CAVA Group (NYSE: CAVA) was initiated with an Outperform rating and $93 price target by Wolfe Research.
Delta Air Lines (NYSE: DAL) had its price target lowered to $71 from $82 by TD Cowen, maintaining a Buy rating.
Deere & Company (NYSE: DE) had its price target lowered to $625 from $675 by Citigroup, maintaining a Neutral rating.
Dollar General (NYSE: DG) had its price target raised to $165 from $159 by Wolfe Research.
Dollar General (NYSE: DG) was reiterated Market Perform by Telsey Advisory Group with a $130 price target.
Duke Energy (NYSE: DUK) had its price target raised to $140 from $136 by UBS Group.
Devon Energy (NYSE: DVN) had its price target raised to $44 from $36 by Jefferies.
Devon Energy (NYSE: DVN) had its price target raised to $64 from $58 by Wolfe Research.
DexCom (NASDAQ: DXCM) was reiterated Buy by BTIG with an $85 price target.
Dyne Therapeutics (NASDAQ: DYN) was reiterated Buy by Jefferies Financial Group.
Dyne Therapeutics (NASDAQ: DYN) was reiterated Buy by Chardan Capital with a $38.00 price target.
Brinker International (NYSE: EAT) was initiated with an Outperform rating and a $184.00 price target by Wolfe Research.
Emergent BioSolutions (NASDAQ: EBS) had its price target lowered to $12.00 from $15.00 by HC Wainwright, while maintaining a Buy rating.
Editas Medicine (NASDAQ: EDIT) was reiterated Buy by Chardan Capital with a $3.50 price target.
Editas Medicine (NASDAQ: EDIT) was reiterated Buy by TD Cowen.
Editas Medicine (NASDAQ: EDIT) received a $6.00 price target from Robert W. Baird.
enGene (NASDAQ: ENGN) was reiterated Strong Buy by Raymond James with a $27.00 price target.
enGene (NASDAQ: ENGN) was reiterated Buy by HC Wainwright with a $25.00 price target.
EOG Resources (NYSE: EOG) had its price target raised to $152.00 from $140.00 by Wolfe Research.
EPR Properties (NYSE: EPR) had its price target raised to $58.00 from $54.00 by UBS Group, maintaining a Neutral rating.
Essential Properties Realty Trust (NYSE: EPRT) had its price target raised to $40.00 from $38.00 by UBS Group, maintaining a Buy rating.
Essential Properties Realty Trust (NYSE: EPRT) received a $37.00 price target from Truist Financial.
EQPT (NYSE: EQPT) had its price target lowered to $31.00 from $35.00 by Citigroup, maintaining a Neutral rating.
Equity Residential (NYSE: EQR) had its price target raised to $70.00 from $69.00 by Evercore.
eToro Group (NASDAQ: ETOR) was reiterated Neutral by Goldman Sachs.
EUDA Health (NASDAQ: EUDA) had its price target lowered to $2.75 from $6.00 by Greenridge Global, maintaining a Buy rating.
Evaxion (NASDAQ: EVAX) had its price target lowered to $9.00 from $11.00 by Lake Street Capital, maintaining a Buy rating.
Evaxion (NASDAQ: EVAX) was reiterated Buy by HC Wainwright with a $16.00 price target.
Evergy (NYSE: EVRG) had its price target raised to $89.00 from $82.00 by Barclays, maintaining an Overweight rating.
EyePoint Pharmaceuticals (NASDAQ: EYPT) had its price target raised to $35.00 from $31.00 by Citigroup, maintaining a Buy rating.
5E Advanced Materials (NASDAQ: FEAM) had its price target lowered to $5.75 from $9.25 by HC Wainwright, maintaining a Buy rating.
Ferrovial (NYSE: FER) was downgraded to Hold from Buy by Jefferies Financial Group.
Fidelis Insurance (NASDAQ: FIHL) had its price target raised to $25.00 from $24.00 by UBS Group, maintaining a Buy rating.
Fidelity National Information Services (NYSE: FIS) was initiated with a Buy rating and a $70.00 price target by Goldman Sachs.
Fortrea (NASDAQ: FTRE) was upgraded to Buy from Hold by TD Cowen with a $15.00 price target.
Global Business Travel Group (NASDAQ: GBTG) was reiterated Negative by Morgan Stanley with a $7.00 price target.
Global Business Travel Group (NASDAQ: GBTG) was reiterated Buy by BTIG Research with a $9.00 price target.
Genesco (NYSE: GCO) had its price target lowered to $32.00 from $38.00 by Truist Financial, maintaining a Hold rating.
Grid Dynamics (NASDAQ: GDYN) had its price target lowered to $12.00 from $14.00 by Northland Securities, maintaining an Outperform rating.
GE Vernova (NYSE: GEV) was upgraded to Buy from Sell by Redburn Atlantic, with the price target raised to $1,100 from $560.
G-III Apparel Group (NASDAQ: GIII) was reiterated Market Perform by Telsey Advisory Group with a $34.00 price target.
Global Payments (NYSE: GPN) was initiated with a Neutral rating and an $88.00 price target by Goldman Sachs.
GitLab (NASDAQ: GTLB) was reiterated Cautious by Morgan Stanley with a $29.00 price target.
Getty Realty (NYSE: GTY) had its price target raised to $33.00 from $29.00 by UBS Group, maintaining a Neutral rating.
Hilton Grand Vacations (NYSE: HGV) had its price target raised to $55.00 from $50.00 by JMP Securities, maintaining a Market Outperform rating.
Hims & Hers Health (NASDAQ: HIMS) was upgraded to Buy from Hold by Needham & Company, with a $30.00 price target.
Herc Holdings (NYSE: HRI) had its price target lowered to $165.00 from $185.00 by Citigroup, maintaining a Buy rating.
Heritage Insurance (NASDAQ: HRTG) received a $39.00 price target from Truist Financial.
Henry Schein (NASDAQ: HSIC) was reiterated Market Perform by Leerink Partners.
Heartflow (NASDAQ: HTFL) was reiterated Buy by Canaccord Genuity with a $40.00 price target.
H World Group (NASDAQ: HTHT) was upgraded to Buy from Neutral by UBS Group with a $62.40 price target.
H2O America (NASDAQ: HTO) had its price target raised to $63.00 from $61.00 by Barclays, maintaining an Overweight rating.
ImmunityBio (NASDAQ: IBRX) was reiterated Buy by D. Boral Capital with a $23.00 price target.
Icon (NASDAQ: ICLR) had its price target lowered to $120.00 from $200.00 by Barclays, maintaining an Equal Weight rating.
Information Services Group (NASDAQ: III) had its price target lowered to $5.50 from $7.00 by Barrington Research, maintaining an Outperform rating.
Immix Biopharma (NASDAQ: IMMX) was initiated with an Outperform rating and a $23.00 price target by JMP Securities.
Immuneering (NASDAQ: IMRX) was reiterated Buy by Needham & Company with an $11.00 price target.
Incyte (NASDAQ: INCY) was reiterated Buy by HC Wainwright with a $135.00 price target.
International Seaways (NYSE: INSW) had its price target raised to $80.00 from $63.00 by Deutsche Bank, maintaining a Buy rating.
Invitation Homes (NYSE: INVH) had its price target lowered to $33.00 from $34.00 by Morgan Stanley, maintaining an Equal Weight rating.
IQVIA (NYSE: IQV) was upgraded to Buy from Hold by TD Cowen, with the price target raised to $213.00 from $174.00.
ITT (NYSE: ITT) was initiated with an Equal Weight rating and a $220.00 price target by Barclays.
Jazz Pharmaceuticals (NASDAQ: JAZZ) was reiterated Overweight by Barclays with a $224.00 price target.
Jade Biosciences (NASDAQ: JBIO) was reiterated Outperform by Wedbush with a $24.00 price target.
JetBlue Airways (NASDAQ: JBLU) had its price target lowered to $4.00 from $5.00 by TD Cowen, maintaining a Hold rating.
JD.com (NASDAQ: JD) had its price target lowered to $34.00 from $41.00 by Barclays, maintaining an Overweight rating.
JD.com (NASDAQ: JD) had its price target raised to $40.00 from $37.00 by Nomura, maintaining a Buy rating.
JD.com (NASDAQ: JD) had its price target lowered to $30.00 from $32.00 by Susquehanna, maintaining a Neutral rating.
Jefferies Financial Group (NYSE: JEF) was downgraded to Equal Weight from Overweight by Morgan Stanley with a $49.00 price target.
Kirby (NYSE: KEX) was reiterated Outperform by Evercore with a $138.00 price target.
Karyopharm Therapeutics (NASDAQ: KPTI) was initiated with a Buy rating by Rodman & Renshaw.
Kroger (NYSE: KR) had its price target raised to $71.00 from $68.00 by Citigroup, maintaining a Neutral rating.
Lincoln National (NYSE: LNC) had its price target lowered to $38.00 from $43.00 by TD Cowen, maintaining a Hold rating.
lululemon athletica (NASDAQ: LULU) had its price target lowered to $189.00 from $206.00 by UBS Group, maintaining a Neutral rating.
Southwest Airlines (NYSE: LUV) had its price target lowered to $55.00 from $66.00 by TD Cowen, maintaining a Buy rating.
LyondellBasell Industries (NYSE: LYB) was upgraded to Buy from Hold by Vertical Research.
LyondellBasell Industries (NYSE: LYB) was upgraded to Outperform from Sector Perform by Royal Bank of Canada, with the price target raised to $82.00 from $51.00.
Lyell Immunopharma (NASDAQ: LYEL) was initiated with a Market Outperform rating and a $34.00 price target by JMP Securities.
Live Nation Entertainment (NYSE: LYV) was reiterated Buy by Guggenheim with a $180.00 price target.
Live Nation Entertainment (NYSE: LYV) was reiterated Hold by Jefferies Financial Group.
Maze Therapeutics (NASDAQ: MAZE) had its Buy rating reiterated by BTIG Research, with a price target of $46.00.
MBX Biosciences (NASDAQ: MBX) received a $50.00 price target from Truist Financial, which initiated coverage on the stock.
Medline (NYSE: MDLN) had its price target raised to $60.00 from $55.00 by Tigress Financial, which maintained a Buy rating.
Medline (NYSE: MDLN) also had its Buy rating reiterated by BTIG Research, which kept a $55.00 price target.
Mayville Engineering Company (NYSE: MEC) had its price target raised to $23.00 from $21.00 by DA Davidson, which maintained a Buy rating.
MercadoLibre (NASDAQ: MELI) had its price target lowered to $2,600 from $2,800 by Morgan Stanley, which maintained an Overweight rating.
Mirion Technologies (NYSE: MIR) had its price target cut to $30.00 from $33.00 by JPMorgan Chase & Co., which maintained an Overweight rating.
Martin Marietta Materials (NYSE: MLM) had its price target trimmed to $702 from $706 by Morgan Stanley, which maintained an Overweight rating.
Miller Industries (NYSE: MLR) had its price target raised to $53.00 from $52.00 by DA Davidson, which maintained a Buy rating.
Miller Industries (NYSE: MLR) also received a $44.00 price target from Loop Capital, which initiated coverage.
Macy’s (NYSE: M) had its price target raised to $9.00 from $8.00 by UBS Group, which maintained a Sell rating.
Altria Group (NYSE: MO) had its price target raised to $74.00 from $67.00 by UBS Group, which maintained a Buy rating.
Microsoft (NASDAQ: MSFT) had its Overweight rating reiterated by Barclays.
Microsoft (NASDAQ: MSFT) also had its Outperform rating reiterated by William Blair.
ArcelorMittal (NYSE: MT) was downgraded to Underweight from Overweight by JPMorgan Chase & Co..
Micron Technology (NASDAQ: MU) had its price target raised to $525 from $345 by Susquehanna, which maintained a Positive rating.
Micron Technology (NASDAQ: MU) also had its price target raised to $430 from $385 by Citigroup, which maintained a Buy rating.
SOLV Energy (NYSE: MWH) was initiated with a Buy rating and $32.00 price target by Jefferies Financial Group.
SOLV Energy (NYSE: MWH) was initiated with an Overweight rating and $34.00 price target by JPMorgan Chase & Co..
SOLV Energy (NYSE: MWH) was initiated with a Buy rating and $42.00 price target by UBS Group.
SOLV Energy (NYSE: MWH) was initiated with an Outperform rating and $34.00 price target by Evercore.
SOLV Energy (NYSE: MWH) was initiated with a Buy rating and $37.00 price target by Guggenheim.
SOLV Energy (NYSE: MWH) was initiated with an Overweight rating and $34.00 price target by KeyCorp.
SOLV Energy (NYSE: MWH) was initiated with an Outperform rating and $36.00 price target by Robert W. Baird.
SOLV Energy (NYSE: MWH) was initiated with a Buy rating and $35.00 price target by Roth MKM.
SOLV Energy (NYSE: MWH) was initiated with an Outperform rating and $35.00 price target by Wolfe Research.
SOLV Energy (NYSE: MWH) was initiated with a Buy rating and $32.00 price target by TD Cowen.
Netflix (NASDAQ: NFLX) was initiated with an Equal Weight rating and $105.00 price target by Wells Fargo & Company.
NNN REIT (NYSE: NNN) had its price target raised to $45.00 from $43.00 by UBS Group, which maintained a Neutral rating.
NRx Pharmaceuticals (NASDAQ: NRXP) had its Buy rating reiterated by D. Boral Capital, with a $34.00 price target.
NETSTREIT (NYSE: NTST) had its price target raised to $24.00 from $21.00 by UBS Group, which maintained a Buy rating.
Nu Holdings (NYSE: NU) had its Neutral rating reiterated by Bank of America.
Nayax (NASDAQ: NYAX) had its Outperform rating reiterated by William Blair.
Orthofix Medical (NASDAQ: OFIX) had its price target lowered to $18.00 from $22.00 by Stifel Nicolaus, which maintained a Buy rating.
Olema Pharmaceuticals (NASDAQ: OLMA) had its Outperform rating reiterated by Oppenheimer.
Olema Pharmaceuticals (NASDAQ: OLMA) had its Buy rating reiterated by TD Cowen.
Olema Pharmaceuticals (NASDAQ: OLMA) had its price target cut to $38.00 from $45.00 by HC Wainwright, which maintained a Buy rating.
Oracle (NYSE: ORCL) had its price target reduced to $230.00 from $310.00 by Barclays, which maintained an Overweight rating.
Oracle (NYSE: ORCL) had its price target cut to $215.00 from $220.00 by Scotiabank, which maintained a Sector Outperform rating.
Oracle (NYSE: ORCL) had its price target lowered to $300.00 from $375.00 by Deutsche Bank Aktiengesellschaft, which maintained a Buy rating.
Realty Income (NYSE: O) had its price target raised to $72.00 from $66.00 by UBS Group, which maintained a Buy rating.
ORIC Pharmaceuticals (NASDAQ: ORIC) had its Overweight rating reiterated by Cantor Fitzgerald.
Oshkosh (NYSE: OSK) had its price target raised to $180.00 from $170.00 by Citigroup, which maintained a Buy rating.
Pacific Gas & Electric (NYSE: PCG) was upgraded to Buy from Neutral by UBS Group.
Piedmont Realty Trust (NYSE: PDM) had its price target cut to $10.00 from $11.00 by Truist Financial, which maintained a Buy rating.
Pfizer (NYSE: PFE) had its Outperform rating reiterated by BMO Capital Markets, which maintained a $30.00 price target.
Preformed Line Products (NASDAQ: PLPC) received a $275.00 price target from Loop Capital, which initiated coverage.
Plug Power (NASDAQ: PLUG) had its price target lowered to $1.80 from $2.00 by Jefferies Financial Group, which maintained a Hold rating.
Praxis Precision Medicines (NASDAQ: PRAX) had its Buy rating reiterated by BTIG Research.
Paramount Skydance (NASDAQ: PSKY) was initiated with an Underweight rating and $10.00 price target by Wells Fargo & Company.
Pure Storage (NYSE: PSTG) was upgraded to Outperform from Market Perform by Northland Securities, which also raised its price target to $81.00 from $77.00.
Portillo’s (NASDAQ: PTLO) was initiated with a Peer Perform rating by Wolfe Research.
uniQure (NASDAQ: QURE) was upgraded to Overweight from Equal Weight by Wells Fargo & Company, which also raised its price target to $60.00 from $15.00.
uniQure (NASDAQ: QURE) was upgraded to Outperform from Sector Perform by Royal Bank of Canada, which raised its price target to $35.00 from $11.00.
uniQure (NASDAQ: QURE) had its price target raised to $31.00 from $16.00 by Chardan Capital, which maintained a Buy rating.
Rapport Therapeutics (NASDAQ: RAPP) had its Buy rating reiterated by BTIG Research, which maintained a $47.00 price target.
Rapport Therapeutics (NASDAQ: RAPP) also had its Buy rating reiterated by TD Cowen.
Rubrik (NYSE: RBRK) had its price target cut to $85.00 from $105.00 by Cantor Fitzgerald, which maintained an Overweight rating.
Rubrik (NYSE: RBRK) had its price target reduced to $95.00 from $120.00 by Rosenblatt Securities, which maintained a Buy rating.
Redwire (NYSE: RDW) was upgraded to Buy from Hold by Truist Financial, which also raised its price target to $15.00 from $13.00.
REGENXBIO (NASDAQ: RGNX) had its price target cut to $30.00 from $32.00 by HC Wainwright, which maintained a Buy rating.
Rio Tinto (NYSE: RIO) was downgraded to Neutral from Overweight by JPMorgan Chase & Co..
Rio Tinto (NYSE: RIO) had its price target lowered to $77.00 from $83.00 by Sanford C. Bernstein, which maintained an Outperform rating.
Cartesian Therapeutics (NASDAQ: RNAC) had its Buy rating reiterated by Needham & Company LLC, which maintained a $42.00 price target.
Cartesian Therapeutics (NASDAQ: RNAC) was upgraded to Overweight from Neutral by Cantor Fitzgerald, which set a $16.00 price target.
Cartesian Therapeutics (NASDAQ: RNAC) also had its Buy rating reiterated by BTIG Research.
Root (NASDAQ: ROOT) had its price target cut to $52.00 from $90.00 by UBS Group, which maintained a Neutral rating.
RxSight (NASDAQ: RXST) had its price target lowered to $9.00 from $10.00 by Stifel Nicolaus, which maintained a Hold rating.
Starbucks (NASDAQ: SBUX) was initiated with a Peer Perform rating by Wolfe Research.
Scholastic (NASDAQ: SCHL) had its rating changed to Neutral from Buy by B. Riley Financial, while maintaining a $37.00 price target.
Sea Limited (NYSE: SE) had its Buy rating reiterated by Bank of America, which maintained a $125.00 price target.
Sweetgreen (NYSE: SG) was initiated with a Peer Perform rating by Wolfe Research.
Shake Shack (NYSE: SHAK) was initiated with an Outperform rating and a $118.00 price target by Wolfe Research.
Shopify (NYSE: SHOP) had its price target raised to $150.00 from $125.00 by Jefferies Financial Group, which maintained a Hold rating.
Signet Jewelers (NYSE: SIG) had its Buy rating reiterated by Jefferies Financial Group.
Slide Insurance (NASDAQ: SLDE) had its price target raised to $23.00 from $22.00 by Keefe, Bruyette & Woods, which maintained an Outperform rating.
Semtech (NASDAQ: SMTC) had its price target raised to $100.00 from $90.00 by Susquehanna, which maintained a Positive rating.
Schneider National (NYSE: SNDR) was upgraded to Neutral from Sell by Citigroup, which set a $27.00 price target.
Syndax Pharmaceuticals (NASDAQ: SNDX) had its price target raised to $45.00 from $33.00 by JPMorgan Chase & Co., which maintained an Overweight rating.
StoneX Group (NASDAQ: SNEX) had its Outperform rating reiterated by William Blair.
South Bow (NYSE: SOBO) had its price target raised to $33.00 from $27.00 by Barclays, which maintained an Equal Weight rating.
Scorpio Tankers (NYSE: STNG) had its Underperform rating reiterated by Bank of America.
Sunbelt Rentals Holdings (NYSE: SUNB) was initiated with an Outperform rating by BNP Paribas Exane.
Standex International (NYSE: SXI) had its Outperform rating reiterated by Barrington Research, which maintained a $260.00 price target.
AT&T (NYSE: T) had its Buy rating reiterated by Citigroup, which maintained a $28.00 price target.
Tempus AI (NASDAQ: TEM) had its Outperform rating reiterated by William Blair.
Terex (NYSE: TEX) had its price target lowered to $63.00 from $68.00 by UBS Group, which maintained a Neutral rating.
Timken (NYSE: TKR) had its price target raised to $93.00 from $85.00 by Citigroup, which maintained a Buy rating.
TransMedics Group (NASDAQ: TMDX) had its Outperform rating reiterated by Oppenheimer, which maintained a $150.00 price target.
Tango Therapeutics (NASDAQ: TNGX) had its Buy rating reiterated by HC Wainwright, which maintained a $13.00 price target.
Oncology Institute (NASDAQ: TOI) had its price target raised to $7.00 from $5.00 by Lake Street Capital, which maintained a Buy rating.
Trevi Therapeutics (NASDAQ: TRVI) had its Buy rating reiterated by Needham & Company, which maintained a $9.00 price target.
Toro (NYSE: TTC) had its price target lowered to $92.00 from $100.00 by Northland Securities, which maintained an Outperform rating.
United Airlines (NASDAQ: UAL) had its Overweight rating reiterated by Morgan Stanley, which maintained a $90.00 price target.
Ulta Beauty (NASDAQ: ULTA) had its price target raised to $450.00 from $425.00 by Telsey Advisory Group, which maintained an Outperform rating.
Verizon Communications (NYSE: VZ) had its Neutral rating reiterated by Goldman Sachs, which maintained a $42.00 price target.
Warner Bros. Discovery (NASDAQ: WBD) had its price target lowered to $11.00 from $13.00 by KeyCorp, which maintained an Overweight rating.
Wingstop (NASDAQ: WING) had its Buy rating reiterated by Stifel Nicolaus, which maintained a $425.00 price target.
Wix.com (NASDAQ: WIX) had its Outperform rating reiterated by Oppenheimer, which maintained a $200.00 price target.
Xenon Pharmaceuticals (NASDAQ: XENE) had its Outperform rating reiterated by William Blair.
Zions Bancorporation (NASDAQ: ZION) had its price target raised to $54.00 from $49.00 by Barclays, which maintained an Equal Weight rating.
STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.
